Artificial Intelligence

AI-powered radiology solutions can be used with both chest x-rays and breast cancer detection.

How pharma companies can reduce the risk of failure with AI-based innovations.

How to cultivate trust & connections in life sciences in a time of AI bias.

In this Q&A with Pharmaceutical Executive®, Andrew Hopkins, founder and CEO of Exscientia, reveals how artificial intelligence (AI) is currently being utilized in the pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI.

Accenture’s global life sciences technology lead discusses how the life sciences industry has embraced artificial intelligence.

Korean-based company HoneyNaps developed the algorithm.

The results are published in "Critical Care," an international journal focused on intensive care medicine.

Abid Rahman and Mike DeLuca discuss developing the AI-powered chatbot.

Arkell discusses the need to democratize AI for the healthcare industry.

The virtual health and remote care company is partnering with BioIntelliSense and Stel Life.

Several of Gleamer’s digital products will be incorporated into the ConcertAI platform.

The imaging company signed deals with Prism Technologies Limited, Paragon Care, and Kral Medical Solutions.

The Magentiq-Colo can be used for real-time results during colonoscopies.

Snyder discusses Eversana’s partnership with Amazon Web Services and how they’re working to bring generative AI to the life sciences industry.

UltraSight says the technology allows for more widespread detection of heart disease.

Harhen discusses how new technologies are being used to reduce the failure rate of new drugs.

The platform will utilize AI-powered software.

Dr. Yocca describes how BioXcel used AI to improve the drug development and re-innovation process.

At the DTX Summit held in Washington DC on June 6-9, 2023, Dr. Hansa Bhargava participated in a panel discussion about putting the patient and provider first in the field of digital therapeutics. After the event, she sat with MD&T to further discuss how education around new therapies is impacting patients and providers.

Poulidis discusses how AI is being used by the pharma industry for marketing and sales.

Chan discusses the AI imaging technology recently used alongside a steerable needle during a successful lung biopsy.

Wood discusses how AI is being used to improve the process of finding patients for clinical trials.

Part of multi-year partnership focusing on drug development in NASH and oncology.

AI-READI study will collect and release a flagship medical dataset intended to accelerate machine learning applications and generate novel hypotheses about Type 2 Diabetes Mellitus.

Acquisition of Blackford Analysis is intended to advance Bayer’s position in digital medical imaging.

Avenda Health's iQuest combines existing patient-specific diagnostic information and deep-learning algorithms.

Innovative and continuous remote patient monitoring, along with AI-based predictive analytics, are advancing progress toward replacing the one-size-fits-all, population-driven vaccination model.

The link between artificial intelligence and human capital warrant legal protection for the latter

Addressing misconceptions as industry becomes more familiar with AI and ML.